Medidata Solutions
2019
Outcome
Expanded Dassault Systèmes beyond manufacturing into biopharma, powering over half of all FDA clinical trials and generating over €1 billion in ARR.
Dassault Systèmes
Acquisitions
3
Major Deals Covered
This page covers 3 major deals from 1997 to 2019, each with its price where disclosed and the reason behind it.
| Company | Year | Price | Purpose |
|---|---|---|---|
| Medidata Solutions | 2019 | Undisclosed | Acquired premier cloud platform for clinical trials to establish a dominant software franchise in life sciences and pharmaceutical research. |
| SolidWorks Corporation | 1997 | Undisclosed | Acquired pioneer of Windows-based 3D parametric CAD software to capture mainstream mechanical engineering design. |
| Exa Corporation | 2017 | Undisclosed | Acquired leading provider of simulation software for fluid flow, aerodynamics, and thermal simulation (PowerFLOW). |
2019
Expanded Dassault Systèmes beyond manufacturing into biopharma, powering over half of all FDA clinical trials and generating over €1 billion in ARR.
2017
Integrated into SIMULIA, enabling automotive and aerospace clients to simulate aerodynamic drag and acoustic noise without physical wind tunnels.
1997
Grew SOLIDWORKS into the world's most popular CAD tool, serving over 6 million designers and generating substantial annual recurring cash flows.
Dassault Systèmes's growth strategy centers on three transformative pillars: accelerating cloud migration to 3DEXPERIENCE SaaS, expanding Virtual Twin applications in life sciences and precision medicine, and driving sustainable circular economy modeling. The company is actively transitioning its extensive on-premise CATIA and SOLIDWORKS user base to the cloud-native 3DEXPERIENCE platform, unlocking higher annual recurring revenue (ARR) per seat through embedded collaboration and generative AI design tools. In healthcare, Dassault is pioneering "Virtual Twin of the Human," modeling human organs to simulate drug toxicity and surgical interventions prior to clinical deployment. Concurrently, Dassault is expanding into green architecture and smart cities, enabling urban planners to simulate airflow, thermal efficiency, and transit logistics.
Dassault Systèmes generates revenue through enterprise software licenses, recurring software subscriptions and support, and professional implementation services. Software revenue represents approximately 90% of total revenue, with recurring revenue (annual cloud SaaS subscriptions and maintenance renewals) accounting for over 80% of software sales, providing exceptional financial predictability. In Manufacturing, large multinational accounts purchase enterprise 3DEXPERIENCE and CATIA deployments under multi-year enterprise agreements, while hundreds of thousands of mid-market engineering firms access SOLIDWORKS through global value-added resellers. In Life Sciences, Medidata contracts recurring multi-year SaaS agreements with global pharmaceutical companies and contract research organizations (CROs) to run decentralized clinical trials and patient data analytics.
Yes, Dassault Systèmes executes targeted acquisitions to integrate complementary technologies, expand intellectual property, and enter new market verticals.
Dassault Systèmes focuses on bolt-on acquisitions that can be rapidly integrated into its core technology architecture and commercial distribution channels.
Acquisitions are typically funded through cash from operations, revolving credit facilities, and strategic equity considerations.
Dassault Systèmes has acquired specialized technology assets that enhance its core platform capabilities and expand its addressable customer base.
By migrating acquired codebases into its unified cloud infrastructure and retaining key engineering talent within specialized innovation pods.
Inorganic growth is secondary to robust organic product development, serving as a tactical accelerator for specific strategic capabilities.
Explore Dassault Systèmes
Core profile pages, founders and related research hubs for this company.